Search - Prime Therapeutics

540 Results for GLP-1 Pipeline Update

Research: The impact of cardiometabolic care management in obesity treatment

A Prime Therapeutics research poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) explores the use of GLP-1 medications to treat obesity when paired...

Prime Article: Research & Publications PA Research & Publications: Research posters & abstracts
Prime presents at AMCP Nexus 2024 on Oct. 14–17

Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.

PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Events
Drug Approvals Monthly Update: January 2024

Drug Approvals Monthly Update: January 2024 Traditional New drugs 1/05/2024 Zelsuvmi™ (berdazimer): The FDA approved Zelsuvmi for the topical treatment of molluscum contagiosum (MC) in adult and...
Drug Approvals Monthly Update: February 2024

Drug Approvals Monthly Update: February 2024 Specialty New drugs 2/16/2024 Amtagvi™ (lifileucel) The United States (U.S.) Food and Drug Administration (FDA) approved the first-in-class...